151 related articles for article (PubMed ID: 38158644)
1. Diabetic neuropathy: A NRF2 disease?
Neagu M; Constantin C; Surcel M; Munteanu A; Scheau C; Savulescu-Fiedler I; Caruntu C
J Diabetes; 2023 Dec; ():. PubMed ID: 38158644
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective.
Hashemi M; Zandieh MA; Ziaolhagh S; Mojtabavi S; Sadi FH; Koohpar ZK; Ghanbarirad M; Haghighatfard A; Behroozaghdam M; Khorrami R; Nabavi N; Ren J; Reiter RJ; Salimimoghadam S; Rashidi M; Hushmandi K; Taheriazam A; Entezari M
Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166714. PubMed ID: 37028606
[TBL] [Abstract][Full Text] [Related]
3. NRF2, a Transcription Factor for Stress Response and Beyond.
He F; Ru X; Wen T
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32640524
[TBL] [Abstract][Full Text] [Related]
4. Role of Nrf2 dysfunction in the pathogenesis of diabetic nephropathy: Therapeutic prospect of epigallocatechin-3-gallate.
Mohan T; Narasimhan KKS; Ravi DB; Velusamy P; Chandrasekar N; Chakrapani LN; Srinivasan A; Karthikeyan P; Kannan P; Tamilarasan B; Johnson T; Kalaiselvan P; Periandavan K
Free Radic Biol Med; 2020 Nov; 160():227-238. PubMed ID: 32768570
[TBL] [Abstract][Full Text] [Related]
5. The Natural Rotenoid Deguelin Ameliorates Diabetic Neuropathy by Decreasing Oxidative Stress and Plasma Glucose Levels in Rats via the Nrf2 Signalling Pathway.
Chen J; Liu W; Yi H; Hu X; Peng L; Yang F
Cell Physiol Biochem; 2018; 48(3):1164-1176. PubMed ID: 30045011
[TBL] [Abstract][Full Text] [Related]
6. Expression of Nrf2 Promotes Schwann Cell-Mediated Sciatic Nerve Recovery in Diabetic Peripheral Neuropathy.
Tang W; Chen X; Liu H; Lv Q; Zou J; Shi Y; Liu Z
Cell Physiol Biochem; 2018; 46(5):1879-1894. PubMed ID: 29719281
[TBL] [Abstract][Full Text] [Related]
7. Normal and Pathological NRF2 Signalling in the Central Nervous System.
Heurtaux T; Bouvier DS; Benani A; Helgueta Romero S; Frauenknecht KBM; Mittelbronn M; Sinkkonen L
Antioxidants (Basel); 2022 Jul; 11(8):. PubMed ID: 35892629
[TBL] [Abstract][Full Text] [Related]
8. SP600125 suppresses
Zhang H; Liu X; Zhou S; Jia Y; Li Y; Song Y; Wang J; Wu H
J Mol Endocrinol; 2018 Feb; 60(2):145-157. PubMed ID: 29273684
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic Insights and Potential Therapeutic Implications of NRF2 in Diabetic Encephalopathy.
Cheng X; Tan Y; Li H; Zhang Z; Hui S; Zhang Z; Peng W
Mol Neurobiol; 2024 Mar; ():. PubMed ID: 38483656
[TBL] [Abstract][Full Text] [Related]
10. Chlorogenic acid prevents diabetic nephropathy by inhibiting oxidative stress and inflammation through modulation of the Nrf2/HO-1 and NF-ĸB pathways.
Bao L; Li J; Zha D; Zhang L; Gao P; Yao T; Wu X
Int Immunopharmacol; 2018 Jan; 54():245-253. PubMed ID: 29161661
[TBL] [Abstract][Full Text] [Related]
11. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
[TBL] [Abstract][Full Text] [Related]
12. Role of nuclear factor (erythroid-derived 2)-like 2 in metabolic homeostasis and insulin action: A novel opportunity for diabetes treatment?
Yu ZW; Li D; Ling WH; Jin TR
World J Diabetes; 2012 Jan; 3(1):19-28. PubMed ID: 22253942
[TBL] [Abstract][Full Text] [Related]
13. Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC.
Dong W; Jia Y; Liu X; Zhang H; Li T; Huang W; Chen X; Wang F; Sun W; Wu H
J Endocrinol; 2017 Jan; 232(1):71-83. PubMed ID: 27799462
[TBL] [Abstract][Full Text] [Related]
14. Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function.
Li Z; Guo H; Li J; Ma T; Zhou S; Zhang Z; Miao L; Cai L
Clin Sci (Lond); 2020 Sep; 134(18):2469-2487. PubMed ID: 32940670
[TBL] [Abstract][Full Text] [Related]
15. Modulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseases.
Pajares M; Cuadrado A; Rojo AI
Redox Biol; 2017 Apr; 11():543-553. PubMed ID: 28104575
[TBL] [Abstract][Full Text] [Related]
16. A Review of the Potential of Nuclear Factor [Erythroid-Derived 2]-like 2 Activation in Autoimmune Diseases.
Ates I; Yılmaz AD; Buttari B; Arese M; Saso L; Suzen S
Brain Sci; 2023 Oct; 13(11):. PubMed ID: 38002492
[TBL] [Abstract][Full Text] [Related]
17. WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling.
Zhou X; Liu Z; Ying K; Wang H; Liu P; Ji X; Chi T; Zou L; Wang S; He Z
Oxid Med Cell Longev; 2020; 2020():7950457. PubMed ID: 32566101
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1.
Sun W; Liu X; Zhang H; Song Y; Li T; Liu X; Liu Y; Guo L; Wang F; Yang T; Guo W; Wu J; Jin H; Wu H
Free Radic Biol Med; 2017 Jul; 108():840-857. PubMed ID: 28457936
[TBL] [Abstract][Full Text] [Related]
19. The KEAP1-NRF2 System and Neurodegenerative Diseases.
Uruno A; Yamamoto M
Antioxid Redox Signal; 2023 May; 38(13-15):974-988. PubMed ID: 36930785
[No Abstract] [Full Text] [Related]
20. Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathy.
Ganesh Yerra V; Negi G; Sharma SS; Kumar A
Redox Biol; 2013 Aug; 1(1):394-7. PubMed ID: 24024177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
